Back to Search
S MCCACHREN, MD
MD
Hematology & Oncology Physician
NPI: 1639149867Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
26117(TN)27248(NC)
Research & Publications (4)
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
PMID 15447994·Clin Cancer Res·2004
3-trial
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
PMID 15073859·Cancer·2004
3-trial
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies.
PMID 14770445·Cancer·2004
3-trial
Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma.
PMID 11773179·J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 220 BMH CANCER CENTER
MARYVILLE, TN 37804 - Phone
- (865) 977-1065
Quick Facts
- NPI
- 1639149867
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 4
Are you this provider?
Claim Your Profile